PER 0.00% 10.0¢ percheron therapeutics limited

investor pres announcement. , page-13

  1. 13,950 Posts.
    lightbulb Created with Sketch. 131
    Its our duty as shareholders to turn on the bullshit radar and stress test our holdings.

    There's been a song and dance about how our management are straight shooters and they seem to be. However I don't like slide 13 in the presentation one little bit. I have two issues with it. One, its misleading. And two they have a throw away line about monkey tests being completed.

    Given the need to do the monkey business twice, I thought it deserved at least one complete slide to fully explain to potential investors WTF were the issues, what were the results and what impact it has on Phase 2b.

    Slide 13 implies we are comparable to Tysabri but nowhere does it say that is based on dosing that was not cleared by the monkey business.

    It fuggin shits me. And if Gas comes back cutting n pasting Mark's intention to go to the FDA, I'll just crack up.
 
watchlist Created with Sketch. Add PER (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.